与西班牙肌缩侧面硬化症相关的临床和社会人口学因素:试点研究
Belén Proaño1, María Cuerda-Ballester2, Noelia Daroqui-Pajares2
1Doctoral Degree School, Health Sciences, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.
Journal of clinical medicine
|October 16, 2024
概括
肌缩侧面硬化症 (ALS) 的危险因素包括职业暴露和以前的癌症. 这些因素也可能影响ALS患者的BMI和呼吸功能,突显了与疾病的潜在联系.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 环境健康 环境健康
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种神经退行性疾病,原因不明.
- 虽然男性性别是已知的危险因素,但早期和成年期暴露的证据仍然不一致.
- 研究临床,社会人口统计学和职业因素对于了解ALS至关重要.
研究的目的:
- 探索临床,社会人口统计学和职业因素与西班牙ALS患者之间的关联.
- 评估这些因素对ALS患者的功能影响.
- 确定潜在的风险因素及其对疾病进展的影响.
主要方法:
- 一项横截面研究,比较ALS患者 (n=59) 和健康对照组 (n=90).
- 收集的数据包括吸烟,高血压,2型糖尿病,以前的癌症 (生殖器官/乳腺),职业暴露和早期生命暴露.
- 在ALS患者中的功能与每个暴露变量相关分析.
主要成果:
- 患有ALS的患者与先前的癌症 (p=0.011),职业暴露 (p<0.001) 和有较大的兄弟姐妹 (p=0.029) 有显著的关联.
- 根据高血压和较大的兄弟姐妹状态,观察到身体质量指数 (BMI) 的显著差异.
- 在有癌症史的患者中,呼吸功能受到显著影响 (p=0.031).
结论:
- 职业暴露和以前的癌症 (生殖器官/乳腺) 可能与ALS有关.
- 高血压和以前的癌症可能会对ALS患者的BMI和呼吸功能产生负面影响.
- 长时间吸烟和接触较大的兄弟姐妹也可能是ALS患者的特征.
相关概念视频
Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449


